Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women

This publication has 30 references indexed in Scilit:

• The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women*1
  Obstetrics & Gynecology, 1998
• Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
  New England Journal of Medicine, 1997
• A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
  Journal of Bone and Mineral Research, 1996
• Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer's Disease: A Population-based Case-Control Study
  American Journal of Epidemiology, 1994
• Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
  Journal of Clinical Investigation, 1994
• Changes in Facial Recognition Memory Across the Adult Life Span
  Journal of Gerontology, 1992
• Effects of phosphatidylserine in age‐associated memory impairment
  Neurology, 1991
• Name recall performance across the adult life‐span
  British Journal of Psychology, 1990
• Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels
  Life Sciences, 1983
• Replacement therapy with piperazine oestrone sulphate('Harmogen') and its effect on memory
  Current Medical Research and Opinion, 1976